OR WAIT null SECS
June 06, 2019
ERS Genomics and Bioneer have revealed the signing of a license agreement for access to CRISPR/Cas9 genome editing technology intellectual property.
European midmarket private equity group, Duke Street, has agreed to acquire Kent Pharmaceuticals and Athlone Laboratories from DCC Vital.
CPI, has supported a project focused on developing and integrating novel recombinant prokaryotic lectins (RPLs) into a biosensor-based platform.
June 02, 2019
Big Pharma is partnering with Alphabet company, Verily, to modernize clinical trials and accelerate time-to-market for drugs.
May 31, 2019
Cannuba has announced that it is collaborating with an independent scientific body on drugs from the UK on the launch of a medical cannabis working group.
CDMO, Vibalogics, has revealed that it will be acquired by a private equity firm, Ampersand Capital Partners.
May 28, 2019
The company says it will work with payers to create payment options for its recently approved gene therapy, Zolgensma (onasemnogene abeparvovec-xioi), priced at $2.125 million.
May 24, 2019
A new partnership is aiming to advance the use of sublingual delivery technology for challenging drugs.
May 23, 2019
The companies will develop a new generation of biotherapeutics from cell-line development through to GMP manufacturing.
May 22, 2019
Cegedim, has announced that it is collaborating with Sanofi to deliver real-world data for the improvement of health within Europe.